mRNA and Stem Cell Synergy for Liver Cirrhosis Treatment
Program: Applied Biotechnology Master's Degree — Business Management
Host Company: Moderna/CSL
Location: Massachusetts (remote)
Student: Carlos Cardona
Overall the objective was to find a therapeutic for liver cirrhosis. In this case dual therapy mRNA and USCs. The only issue is that one would need to find the protein that triggers the scarring, and have it activated, and that would hopefully reverse it.